The Role of Serum Cytokeratin 19 Fragment in Transarterial Infusion against Invasive Bladder Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2160-5440
ISSN Online: 2160-5629
www.scirp.org/journal/oju
E-mail: oju@scirp.org

Citations

"The Role of Serum Cytokeratin 19 Fragment in Transarterial Infusion against Invasive Bladder Cancer"
written by Ryo Takahashi, Ryoji Kimata, Shunichiro Nomura, Ichiro Matsuzawa, Yasutomo Suzuki, Tsutomu Hamasaki, Yukihiro Kondo,
published by Open Journal of Urology, Vol.3 No.3, 2013

has been cited by the following article(s):

[1]	Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy: DYRK2 is associated with survival in bladder cancer
	BMC urology, 2015

[2]	评估膀胱癌新辅助化疗效果的生物标志物研究进展
	中华泌尿外科杂志, 2015

[3]	Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy
	BMC urology, 2015

[4]	Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving …
	2015

[5]	Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant …
	BMC urology, 2015

[6]	Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis
	BMC urology, 2013

Follow SCIRP